SPDW vs VXUS: Is a State Street or Vanguard International ETF the Better Fit for Your Portfolio?
Source: The Motley Fool
The article favors State Street's SPDW over Vanguard's VXUS, citing SPDW's higher trailing 12-month yield of 3.1% versus 2.4%, lower expense ratio of 0.03% versus 0.05%, and higher annualized returns across the 3-, 5-, and 10-year periods: 22%, 9%, and 10% versus 20%, 8%, and 9%. VXUS offers broader exposure by including emerging markets, while SPDW focuses on developed markets; the article notes past performance does not guarantee future results.
Analysis
This is an allocation choice, not a persuasive standalone alpha signal. The developed-markets fund leaves investors more exposed to Japan and Europe and to its developed-market sector mix; the total-international fund adds an emerging-markets sleeve. That difference can dominate a 2 bp annual fee gap: on $1 million, the fee difference is roughly $200 a year, before tracking and trading effects. The quoted yield gap is not a durable return advantage—distributions vary and should be assessed alongside total return and tax treatment.
The reported outperformance across lookbacks is not a reliable forecast. It may reflect country, currency, and sector leadership that can reverse; notably, exposure to Asian semiconductor companies creates a shared cyclical risk rather than a clean diversification distinction. Over days to months, relative performance is likely to be sensitive to the U.S. dollar, China/EM risk appetite, and semiconductor expectations. Over 6–18 months, the key question is whether investors are being compensated for EM policy, currency, and governance risks—not which fund recently led.
Contrarian point: broader country coverage is not automatically lower risk, while recent developed-market outperformance is not evidence of persistent superiority. The article’s annualized-return figures should be reconciled with its other return data and checked against consistent dates, benchmarks, and distribution treatment before acting.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Key Decisions for Investors
- Avoid switching based solely on trailing returns or yield. Choose the developed-markets fund if EM exposure is intentionally excluded; choose the total-international fund if the portfolio needs a market-cap-weighted EM allocation.
- For a 1–3 month relative-value view, consider a small long total-international / short developed-markets position only if expecting EM equities to outperform; size for currency and China-related gap risk. No trade if there is no explicit EM view.
- Before reallocating, verify comparable total-return periods, index methodology, current country weights, and distribution data. Treat any material inconsistency as a reason to defer the switch.
- Falsify an EM-outperformance thesis if EM relative performance continues to weaken alongside deteriorating earnings revisions or renewed dollar strength; reassess a developed-market preference if its relative gains are driven mainly by a narrow semiconductor rally.
More News
- Magnificent 7 loses $1 trillion. The most eye-popping stats from Thursday's tech stock plunge
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Wall Street’s best post-midterm rally in 44 years lasted just one day—then $3 trillion vanished as chip stocks plunged over AI fears
- Equity Volatility Jumps Most Since April 2025 Tariff Turmoil
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- We're raising our price target on Cardinal Health after another stellar quarter of profits